Table 1.
Clinical demographics, angiographic characteristics, and functional parameters in the patient study
| Characteristic | STEMI patients (n = 49) |
|---|---|
| Male sex | 37 (76%) |
| Age (years) | 59 ± 9 |
| Weight (kg) | 85 ± 14 |
| BMI (kg/m2) | 27 ± 3 |
| CAD risk factors | |
| Diabetes | 7 (14%) |
| Hypertension | 38 (78%) |
| Hypercholesterolaemia | 8 (16%) |
| Smoking history | 41 (84%) |
| Family history | 33 (67%) |
| Functional parameters assessed by CMR at 4–6 days | |
| LVEDV (mL) | 90.5 ± 18.5 |
| LVESV (mL) | 45.5 ± 16.8 |
| LVEF (%) | 50.9 ± 8.2 |
| Infarct size (% of the LV) | 17.5 ± 12.3 |
| Time to reperfusion (h) | 2.6 ± 1.3 |
| CK-MB peak (U/L) | 176 ± 183 |
| Infarct-related artery | |
| LAD | 27 (55%) |
| LCx | 5 (10%) |
| RCA | 17 (35%) |
| Thienopyridine | 49 (100%) |
| Platelet glycoprotein IIb/IIIa inhibitors | 14 (29%) |
| TIMI 3 flow grade post-PCI | 46 (94%) |
| Incomplete (≤70%) ST-segment resolution post-PCI | 28 (57%) |
Data are n or mean ± SD.
BMI, body mass index; CAD, coronary artery disease; CMR, cardiovascular magnetic resonance; LV, left ventricle; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LVEF, left ventricular ejection fraction; CK-MB, creatine kinase-myocardial band; PCI, percutaneous coronary intervention.